To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

A SCA7 premutation may be… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

A SCA7 premutation may be a novel Mendelian modifier of MS course: A case report

Journal article
Authors Christina Sundal
Markus Axelsson
L. Wiklund
Christopher Lindberg
Oluf Andersen
Published in Multiple Sclerosis and Related Disorders
Volume 31
Pages 148-150
ISSN 2211-0348
Publication year 2019
Published at Institute of Biomedicine, Department of Medical and Clinical Genetics
Institute of Neuroscience and Physiology, Department of Clinical Neuroscience
Pages 148-150
Language en
Links dx.doi.org/10.1016/j.msard.2019.04....
Keywords Comorbidity, Mendelian, Multiple sclerosis, Premutation, SCA7, ataxin 7, adult, Article, ATXN7 gene, case report, cerebellar ataxia, clinical article, clinical feature, disability, disease course, disease severity, follow up, gene mutation, human, male, nuclear magnetic resonance imaging, onset age, polymerase chain reaction
Subject categories Neurosciences, Medical Genetics

Abstract

A proportion of patients with the phenotype of complex genetic disorders carry dominantly inherited Mendelian traits, exemplified by hereditary spastic paraparesis influencing pyramidal symptoms in some MS cases. We here describe a mutable ATXN7 gene, a SCA7 premutation, in a patient fulfilling contemporary definitions of primary progressive MS. His onset age, and onset with a severely progressive cerebellar ataxia syndrome, was outside the reported range of symptoms in a representative MS material. We suggest that an ATXN7 premutation is a novel genetic modifier of the course of MS. © 2019

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?